Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Quan

Showing results (221-230 of 258) with videos related to

Pageof 26
Sort By:
Archives of Dermatological Research|April 28, 2020
Incorporation of dermoscopy improves inter-observer agreement among dermatopathologists in histologic assessment of melanocytic neoplasmsKatherine Shi, Elsy Compres, Kara E Walton, et al.
Annals of Emergency Medicine|April 6, 2001
Automated external defibrillation/public access defibrillationD L Atkins, L L Bossaert, M F Hazinski, et al.
Journal of the American Academy of Dermatology|November 16, 2017
The diagnostic value and histologic correlate of distinct patterns of shiny white streaks for the diagnosis of melanoma: A retrospective, case-control studyAnna Eliza Verzi, Victor L Quan, Kara E Walton, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Nonbenzamidine isoxazoline derivatives as factor Xa inhibitorsMimi L Quan, Christopher D Ellis, Ming Y He, et al.
Journal of the American Academy of Dermatology|July 16, 2019
Distinct genomic features in a retrospective cohort of mucosal, acral, and vulvovaginal melanomasKatherine Shi, Bin Zhang, Betty Y Kong, et al.
International Journal of Radiation Oncology, Biology, Physics|June 7, 2005
Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiformeAimee L Quan, Gene H Barnett, Shih-Yuan Lee, et al.
Journal of Medicinal Chemistry|July 30, 1999
Design and synthesis of isoxazoline derivatives as factor Xa inhibitors. 1M L Quan, A Y Liauw, C D Ellis, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2010
Phenyltriazolinones as potent factor Xa inhibitorsMimi L Quan, Donald J P Pinto, Karen A Rossi, et al.
Cell Death & Disease|May 6, 2016
SP6616 as a new Kv2.1 channel inhibitor efficiently promotes β-cell survival involving both PKC/Erk1/2 and CaM/PI3K/Akt signaling pathwaysT T Zhou, L L Quan, L P Chen, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Pyrazoles, 1,2,4-triazoles, and tetrazoles as surrogates for cis-amide bonds in boronate ester thrombin inhibitorsJ V Duncia, J B Santella, C A Higley, et al.
Pageof 26

Showing results (221-230 of 258) with videos related to

Sort By:
Pageof 26
Archives of Dermatological Research|April 28, 2020
Incorporation of dermoscopy improves inter-observer agreement among dermatopathologists in histologic assessment of melanocytic neoplasmsKatherine Shi, Elsy Compres, Kara E Walton, et al.
Annals of Emergency Medicine|April 6, 2001
Automated external defibrillation/public access defibrillationD L Atkins, L L Bossaert, M F Hazinski, et al.
Journal of the American Academy of Dermatology|November 16, 2017
The diagnostic value and histologic correlate of distinct patterns of shiny white streaks for the diagnosis of melanoma: A retrospective, case-control studyAnna Eliza Verzi, Victor L Quan, Kara E Walton, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Nonbenzamidine isoxazoline derivatives as factor Xa inhibitorsMimi L Quan, Christopher D Ellis, Ming Y He, et al.
Journal of the American Academy of Dermatology|July 16, 2019
Distinct genomic features in a retrospective cohort of mucosal, acral, and vulvovaginal melanomasKatherine Shi, Bin Zhang, Betty Y Kong, et al.
International Journal of Radiation Oncology, Biology, Physics|June 7, 2005
Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiformeAimee L Quan, Gene H Barnett, Shih-Yuan Lee, et al.
Journal of Medicinal Chemistry|July 30, 1999
Design and synthesis of isoxazoline derivatives as factor Xa inhibitors. 1M L Quan, A Y Liauw, C D Ellis, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2010
Phenyltriazolinones as potent factor Xa inhibitorsMimi L Quan, Donald J P Pinto, Karen A Rossi, et al.
Cell Death & Disease|May 6, 2016
SP6616 as a new Kv2.1 channel inhibitor efficiently promotes β-cell survival involving both PKC/Erk1/2 and CaM/PI3K/Akt signaling pathwaysT T Zhou, L L Quan, L P Chen, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Pyrazoles, 1,2,4-triazoles, and tetrazoles as surrogates for cis-amide bonds in boronate ester thrombin inhibitorsJ V Duncia, J B Santella, C A Higley, et al.
Pageof 26